期刊文献+

粒细胞-巨噬细胞集落刺激因子壳聚糖缓释纳米粒的制备 被引量:1

Preparation of GM-CSF Loaded Chitosan Nanoparticles
原文传递
导出
摘要 目的:研究以生物可降解壳聚糖纳米粒作为粒细胞-巨噬细胞集落刺激因子(GM-CSF)新型缓释系统的可行性。方法:以三聚磷酸钠为交联剂,采用离子交联法制备负载GM-CSF和牛血清白蛋白(BSA)的纳米粒。用透射电镜观测纳米粒径和形态;用紫外分光光度计、荧光分光光度计分别测定BSA和GM-CSF包封率,并考察制剂体外药物释放情况。结果:纳米粒形态多呈球形,平均粒径为201nm,GM-CSF和BSA包封率分别为62.1%、58.5% ,3d时体外累积释放率分别为69%、82%。结论:应用离子交联法可制备负载GM-CSF的壳聚糖缓释纳米粒。 OBJECTIVE: To study the feasibility of using biodegradable chitosan nanoparticles as new type carriers for control0led GM - CSF delivery system. METHODS: GM - CSF and BSA loaded chitosan nanoparticles were prepared by ion cross linking method using tripolyphosphate as cross- linking agent with its morphology observed by transmission electron microscope. The encapsulating efficiencies of GM - CSF and BSA were determined respectively by fluorescence scanning and ultraviolet spectrophotometer. The in vitro drug release properties of chitosan nanoparticles were studied as well. RESULTS: Morphologically, the nanoparticles were spherical with mean particle size of 201nm. The encapsulating efficiencies of GM- CSF and BSA were 62.1% and 58.5%, respectively, and their in vitro accumulative drug release rates on the 3rd day were 69% and 82% respectively. CONCLUSION: The ion cross linking method is fit for the preparation of GM- CSF loaded chitosan nanoparticles.
作者 李正艳 何应
出处 《中国药房》 CAS CSCD 北大核心 2007年第31期2435-2437,共3页 China Pharmacy
关键词 粒细胞-巨噬细胞集落刺激因子 牛血清白蛋白 壳聚糖 纳米粒 包封率 体外释放 GM- CSF Bovine serum albumin Chitosan Nanoparticles Entrapment efficiency In vitro release
  • 相关文献

参考文献6

二级参考文献29

  • 1张明智,宋永平,范魁生.重组人粒细胞巨噬细胞集落刺激因子治疗骨髓抑制[J].新药与临床,1995,14(1):38-40. 被引量:2
  • 2布卡,盛洁,谢蜀生,魏树礼.抗人膀胱癌免疫毫微球的制备及活性检测[J].中华微生物学和免疫学杂志,1996,16(1):54-57. 被引量:21
  • 3Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles(SLN) for controlled drug delivery-drug release and release mechanism[J].Eur J Pharm Biopharm,1998,45(2) : 149.
  • 4Zara G P, Bargoni A, Cavalli R, et al. Pharmacokinetics and tissue distribution of idarubicin - loaded solid lipid nanoparticles after duodenal administration to rats[J] .J Pharm Scien ,2002,91(5) : 1 324.
  • 5Miglietta A, Cavalli R ,Bocca C, et al. Cellular uptake and cytotoxicity of solid lipid nanospheres incorporation doxorubicin or paclitaxel [ J ] . lnt J Pharm , 2000,210(1-2) :61.
  • 6Westesen K,Bunjes H,Koch MHJ .Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potentia[J] .J Control Release, 1997,48(2-3) :223.
  • 7Heiati H,Tawashi R,Phillips NC.Drug retention and stability of solid lipid, nanoparticles containing azidothymidinepalmitate after autoclaving,storage and lyophilization [J] .J Microencapsul, 1998,15(2) : 173.
  • 8Cavalli R ,Gasco MR ,Barresi AA, et al .Evaporative drying of aqueous dispersions of solid lipid nanoparticles[J]. Drug Dev Ind Pharm , 2001,27(9) : 919.
  • 9Freitas C, Mullera RH. Spray - drying of solid lipid nanoparticles(SLN TM) [J] . Eur J Pharm Biopharm ,1998,46(2):145.
  • 10Avraham H, Ernest VG, Danielle R, et al .Damage to the protein synthesizing apparatus in mouse liver in vivo by magnetocytolysis in the presence of hepatospecific magnetic nanoparticles[J] .J Magnetism and Magnetic Materials , 2002,248 (2) : 276.

共引文献7

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部